NCT07084727Recruiting
Identifying Biomarkers for Endothelial Dysfunction in Women With Preeclampsia
Retinal Biomarkers as a Tool for Early Detection of Endothelial Dysfunction in Women With Preeclampsia
Source: ClinicalTrials.gov · Last updated 24 Jul 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
Every pregnancy has a major impact on a woman's heart and blood vessels due to changes required by the body to maintain proper blood flow between mother and foetus. When the placenta does not work properly, preeclampsia can occur. An important first symptom is high blood pressure. Women who have experienced preeclampsia are at higher risk of developing blood pressure and heart problems later on. Therefore, it is very important to detect changes in the blood vessel system so that they can be treated promptly and correctly. We aim to do this by using a new, non-invasive eye test that examines the blood vessels of the retina.
- Status (registry)
- Recruiting
- Study type
- Interventional
- Enrollment
- 60 (estimated)
- First submitted
- 1 Jul 2025
- Start date
- 1 Jul 2025
- Primary completion date
- 15 Nov 2025
- Lead sponsor
- University Hospital, Antwerp
- NCT number
- NCT07084727
What you commit to
- Study type: Interventional
- Planned participants: 60
- From 1 Jul 2025 to the primary completion date, 15 Nov 2025
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- (gestational) Diabetes
- Kidney disease
- Auto-immune disorders
- Connective tissue diseases
Other
- Unwilling to provide informed consent
- Open-angle glaucoma
- Epilepsia
- Multiple pregnancies
- Fetal malformations
- Hypercholesterolemia
Who the study is looking for
- at least 18 years old
- willing to undergo vascular assessments
- informed consent signed
Age in the registry: 18 years to 40 years · Sex: Female · Accepts healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Antwerp University Hospital Coordinator of this site? Confirm its status | Edegem | Belgium | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.